Suman Chatterjee, Ph.D.
Affiliations: | Biological Sciences | Duquesne University, Pittsburgh, PA, United States |
Area:
Cell biologyGoogle:
"Suman Chatterjee"Mean distance: 17.64 (cluster 28) | S | N | B | C | P |
Parents
Sign in to add mentor| Richard Elinson | grad student | 2013 | Duquesne University | |
| (Differential expression of nodal-signal transducers and global transcriptional repression commit vegetal cells in Eleutherodactylus coqui to form nutritional endoderm.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yochum ZA, Cades J, Wang H, et al. (2018) Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene |
| Han J, Goldstein LA, Hou W, et al. (2018) HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC. Autophagy. 1-14 |
| Yochum ZA, Chatterjee S, Huang EH, et al. (2018) Abstract 5889: TWIST1 is a key mediator of HGF-MET-driven resistance to targeted therapies in EGFR mutant and MET-driven lung cancer Cancer Research. 78: 5889-5889 |
| Chatterjee S, Burns TF. (2017) Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. International Journal of Molecular Sciences. 18 |
| Yochum ZA, Cades J, Mazzacurati L, et al. (2017) A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-driven Lung Cancer. Molecular Cancer Research : McR |
| Chatterjee S, Huang EH, Christie I, et al. (2017) Reactivation of the p90RSK-CDC25C pathway leads to bypass of the ganetespib induced G2/M arrest and mediates acquired resistance to ganetespib in KRAS mutant NSCLC. Molecular Cancer Therapeutics |
| Chatterjee S, Huang EH, Christie I, et al. (2017) Acquired resistance to the Hsp90 inhibitor, ganetespib in KRAS mutant NSCLC is mediated via reactivation of the ERK-p90RSK-mTOR signaling network. Molecular Cancer Therapeutics |
| Chatterjee S, Huang EH, Christie I, et al. (2017) Abstract 4152: The p90RSK-CDC25C signaling pathway leads to bypass of the ganetespib induced G2/M arrest and mediates acquired resistance to ganetespib inKRASmutant NSCLC Cancer Research. 77: 4152-4152 |
| Chatterjee S, Huang EH, Burns TF. (2016) Abstract 2942: p90 Ribosomal S6 kinase mediates acquired resistance to ganetespib in KRAS mutant NSCLC Cancer Research. 76: 2942-2942 |
| Chatterjee S, Burns TF. (2015) Abstract 762: Ganetespib resistance inKRASmutant NSCLC is mediated through bypassing the G2/M checkpoint and reactivating the PI3K/MTOR pathway Cancer Research. 75: 762-762 |